论文部分内容阅读
目的:探讨肝门部胆管癌的治疗方法。方法:回顾性分析我院1996￣2004年间52例肝门部胆管癌的临床病例资料。结果:手术切除组、手术引流组、介入支架组及剖腹探查组的平均生存时间分别为19.08、6.6、4.3、1.2个月。围手术期死亡2例。结论:肝门部胆管癌肿瘤切除术疗效明显优于其他治疗方式,对此病患者应积极争取行根治性切除术。对不能切除病例积极行引流术治疗,以延长生命、提高生存质量。
Objective: To investigate the treatment of hilar cholangiocarcinoma. Methods: A retrospective analysis of our hospital from 1996 to 2004, 52 cases of hilar cholangiocarcinoma clinical case data. Results: The average survival time of surgical resection group, surgical drainage group, interventional stent group and laparotomy group were 19.08, 6.6, 4.3 and 1.2 months respectively. Perioperative death in 2 cases. Conclusions: The curative effect of hilar cholangiocarcinoma resection is better than other treatment methods, and the patients with this disease should actively seek radical resection. Positive removal of the case can not be treated drainage to prolong life and improve the quality of life.